FOSTER CITY, Calif. -- The world's largest randomized trial of COVID-19 treatments found "conclusive evidence" that remdesivir, a drug used to treat U.S. President Donald Trump when he fell ill, has ...

In a study it described as both conclusive and disappointing, the World Health Organization said the antiviral drug remdesivir has "little or no effect on mortality for hospitalized patients," and it ...

For the first time, a major study suggests that an experimental drug works against the new coronavirus, and U.S. government officials said Wednesday that they would work to make it available to ...

As efforts to develop an effective vaccine for COVID-19 continue, in parallel, drug developers are investigating the effectiveness of existing drugs at treating patients with COVID-19. The ...

GENEVA — A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the ...

A large study led by the World Health Organization suggests that the antiviral drug remdesivir did not help hospitalized COVID-19 patients, in contrast to an earlier study that made the medicine a ...

Remdesivir, an experimental antiviral drug from Gilead Sciences, led to faster recovery of patients with advanced COVID-19, the disease caused by the new coronavirus, according to data from a ...

As countries grow anxious in re-opening the economy, the invasiveness of the novel coronavirus threatens to prolong the stay-at-home order. Worse still is the high mortality rate on the elderly and ...

Excitement is building over remdesivir as a treatment for COVID-19. On Friday, the Food and Drug Administration authorized the emergency use of remdesivir to treat COVID-19, President Trump announced.

In a recent study published in the Journal of Heterocyclic Chemistry, researchers outlined the synthesis and the possible mechanism of action (MOA) of two potential severe acute respiratory syndrome ...